Using new forms of evolutionary machine learning and adversarial AI (NOT neural networks) we evolve personalised models for people with unstable type-1 diabetes (T1D) and generate better (safer, effective) insulin dosing strategies. The challenge is that there is no 'good' training data: the medical history of unstable T1D is a history of therapeutic failure. Conventional AI is unable to work here but our new forms can, transforming quality of life. This is the Neuromathix artificial pancreas.